Brief: SinoMab BioScience Says On 27 Aug Investigational New Drug Application Of SN1011 For Autoimmune Disease Approved By NMPA
01/09/2020 15:58
Sept 1 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* ON 27 AUGUST INVESTIGATIONAL NEW DRUG APPLICATION OF
SN1011 FOR
AUTOIMMUNE DISEASE BEEN APPROVED BY NMPA OF PRC
Source text for Eikon: urn:newsml:reuters.com:*:nHKS3h1Rsy
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience